Natera | Transforming Management of Genetic Disease.

COVID-19 UPDATE

Introducing the GI Expanded Access Program for remote Signatera ctDNA testing

IN THE NEWS

New Publication in Nature Cancer Demonstrates Signatera’s Ability to Evaluate Tumor Response to Immunotherapy


 

Personalizing cancer
care management

Custom-built testing for each cancer patient, to detect molecular residual disease (MRD) and help guide treatment decisions.

 

Learn more: Oncology

 

Assessing the health
of transplant patients

The most precise cell-free DNA (cfDNA) testing in organ health—developed from our trusted legacy.

 

Learn more: Organ Health

 

Informing women's health decisions

Women’s health testing for every phase of life—from planning a family and checking baby’s health to assessing risk for hereditary cancer.

 

Learn more: Women's Health


OUR CLINICAL EXPERTS

Connect with a genetic counselor remotely in your home or office

Learn More


IN THE NEWS

Panorama NIPT achieves 2 million test milestone.

Learn More


OUR TECHNOLOGY

Natera's core technology and finely tuned workflows cut through the noise to deliver superior clinical and analytical performance.

Learn More